Year: 2021

news_6

Nanjing Leads Biolabs and BeiGene Announce Worldwide License and Collaboration Agreement for LBL-007 Anti-LAG-3 Antibody; BeiGene Granted Exclusive Commercialization Rights Outside of China

CAMBRIDGE, Mass. & BEIJING--(BUSINESS WIRE)--BeiGene (NASDAQ: BGNE; HKEX: 06160), a global science-driven biotechnology company focused on developing innovative and affordable...

news_6

Yuexiu Transport’s Publicly Offered Infrastructure REIT “CAMC-Yuexiu Expressway Close-end Infrastructure Securities Investment Fund” Successfully Listed on Shenzhen Stock Exchange

HONG KONG SAR - Media OutReach - 14 December 2021 - Yuexiu Transport Infrastructure Limited ("Yuexiu Transport Infrastructure" or the "Company", which, together...